View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Take Two Interactive Software Inc: 2 directors

Two Directors at Take Two Interactive Software Inc sold/gave away 5,979 shares at between 0.000USD and 151.255USD. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the co...

OPAL Fuels Inc: 2 directors

Two Directors at OPAL Fuels Inc sold/bought 20,813 shares at between 4.890USD and 5.057USD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...

Coca-Cola Hellenic Bottling Company AG: 1 director

A director at Coca-Cola Hellenic Bottling Company AG sold 3,300 shares at 2,798p and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...

 PRESS RELEASE

EQS-News: Gerresheimer übernimmt Blitz LuxCo Sarl, die Holding Gesells...

EQS-News: Gerresheimer AG / Schlagwort(e): Fusionen & Übernahmen Gerresheimer übernimmt Blitz LuxCo Sarl, die Holding Gesellschaft der Bormioli Pharma Gruppe – Moulded Glass Geschäft wird strategisch neu aufgesetzt 23.05.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Gerresheimer übernimmt Blitz LuxCo Sarl, die Holding Gesellschaft der Bormioli Pharma Gruppe – Moulded Glass Geschäft wird strategisch neu aufgesetzt Strategische Akquisition: Komplementäres Produktportfolio und breite Abdeckung mit Produktionsstandorten in...

 PRESS RELEASE

EQS-News: NFON AG treibt Neuausrichtung auch in Q1 2024 weiter voran u...

EQS-News: NFON AG / Schlagwort(e): Quartals-/Zwischenmitteilung NFON AG treibt Neuausrichtung auch in Q1 2024 weiter voran und steigert Umsatz sowie Profitabilität planmäßig 23.05.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. NFON AG treibt Neuausrichtung auch in Q1 2024 weiter voran und steigert Umsatz sowie Profitabilität planmäßig Anstieg der wiederkehrenden Umsätze um 2,8 % auf 19,9 Mio. EUR im ersten Quartal 2024 Anteil der wiederkehrenden Umsätze am Gesamtumsatz auf 93,6 % gesteigert Deutlich verbessertes berei...

 PRESS RELEASE

EQS-News: SBO mit hohem Umsatz und solidem Betriebsergebnis in Q1 2024...

EQS-News: Schoeller-Bleckmann Oilfield Equipment AG / Schlagwort(e): Quartalsergebnis SBO mit hohem Umsatz und solidem Betriebsergebnis in Q1 2024 trotz herausforderndem US-Markt 23.05.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SBO mit hohem Umsatz und solidem Betriebsergebnis in Q1 2024 trotz herausforderndem US-Markt   Q1-Umsatz von MEUR 146,7 auf hohem Niveau nach Rekord in 2023; EBIT bei MEUR 20,6 AMS-Division setzt hervorragende Performance fort: Umsatz MEUR 81,9; 21,7% EBIT-Marge  Ergebnis der OE-Division ...

 PRESS RELEASE

EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding compan...

EQS-News: Gerresheimer AG / Key word(s): Mergers & Acquisitions Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business 23.05.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business Strategic acquisition: Complementary product portfolio and broad footprint with production sites in Europe Gerresheimer underpins leading marke...

 PRESS RELEASE

EQS-News: NFON AG further advances its reorganisation in Q1 2024 and i...

EQS-News: NFON AG / Key word(s): Quarterly / Interim Statement NFON AG further advances its reorganisation in Q1 2024 and increases revenue and profitability as planned 23.05.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. NFON AG further advances its reorganisation in Q1 2024 and increases revenue and profitability as planned Recurring revenue up 2.8% at EUR 19.9 million in first quarter of 2024 Share of recurring revenue increases to 93.6% of total revenue Significantly improved adjusted EBITDA of EUR 2.8 million results i...

 PRESS RELEASE

EQS-News: SBO with high sales and solid EBIT in Q1 2024 despite compet...

EQS-News: Schoeller-Bleckmann Oilfield Equipment AG / Key word(s): Quarter Results SBO with high sales and solid EBIT in Q1 2024 despite competitive US market 23.05.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. SBO with high sales and solid EBIT in Q1 2024 despite competitive US market Q1 sales of MEUR 146.7 maintained a high level after record in 2023; EBIT at MEUR 20.6 AMS division continued excellent performance: Sales at MEUR 81.9; 21.7% EBIT margin Results of OE division impacted by continued slow US market Bookings...

 PRESS RELEASE

Avance Gas Holding Ltd: Ex cash distribution USD 2.15 today

Avance Gas Holding Ltd: Ex cash distribution USD 2.15 today Hamilton, Bermuda, May 23, 2024 The shares in Avance Gas Holding Ltd (ticker: "AGAS") will be traded ex cash distribution of USD 2.15 per share as of today. The cash distribution of USD 2.15 consists of USD 0.99 in return of capital and USD 1.16 in dividend for the first quarter of 2024. The return of capital and dividend will be paid on May 31, 2024. For further information, please contact: Randi Navdal Bekkelund - Chief Financial Officer Tel: Email: ...

 PRESS RELEASE

Benedicte Schilbred Fasmer is appointed new President & CEO in Telenor...

Benedicte Schilbred Fasmer is appointed new President & CEO in Telenor Group Oslo (May 23rd 2024) - Telenor Group’s Board of Directors has appointed Benedicte Schilbred Fasmer as new President & CEO. Sigve Brekke is stepping down December 1st after more than 9 years as President & CEO of Telenor.   Telenor’s Board of Directors has carried out an extensive process to identify the right candidate for the position of President & CEO, as Sigve Brekke, the current CEO, has a contract that stipulates retirement at the end of 2024. "The board has been looking for the most qualified cand...

Atalaya Mining: 2 directors

A director at Atalaya Mining sold after exercising options 150,000 shares at 482p and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...

Mahindra & Mahindra Limited: 4 directors

Four Directors at Mahindra & Mahindra Limited sold 6,700 shares at between 2,478.900INR and 2,503.000INR. The significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's d...

Paycom Software Inc: 2 directors

Two Directors at Paycom Software Inc gave away/sold 4,900 shares at between 0.000USD and 179.270USD. The significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direct...

Smartgroup Corporation Ltd: 1 director

A director at Smartgroup Corporation Ltd bought 70,000 shares at 8.343AUD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...

Stoke Therapeutics Inc: 3 directors

Three Directors at Stoke Therapeutics Inc sold after exercising options/sold 100,949 shares at between 15.040USD and 15.432USD. The significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades ...

ABGSC Consumer Goods Research ... (+3)
  • ABGSC Consumer Goods Research
  • Daniel Thorsson
  • Simon Granath

Time to beat expectations, up to BUY

Growth returns in Q2e and we expect strong acceleration in H2'24e. Dominant position with impressive financials; we are above consensus. We upgrade to BUY (Hold), TP to SEK 550 (350) for 25% upside.

 PRESS RELEASE

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New D...

Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease Additional kidney function analyses strongly support Vivoryon’s shift in strategic focus to inflammatory and fibrotic diseases, and are a further step towards securing Company’s futureVaroglutamstat`s beneficial effect of improving kidney function, as demonstrated by an increase of estimated glomerular filtration rate (eGFR), confirmed by various sen...

 PRESS RELEASE

AvH annonce d'excellents résultats au premier trimestre, tant pour DEM...

AvH annonce d'excellents résultats au premier trimestre, tant pour DEME que pour les banques privées Delen et Van Breda, et confirme ses perspectives: le bénéfice net pour 2024 devrait être supérieur à celui de l'année dernière Cher actionnaire, Monsieur, Madame, Ackermans & van Haaren a publié aujourd'hui une déclaration intermédiaire pour le premier trimestre 2024, avec les messages clés suivants : Excellents résultats au premier trimestre, tant pour DEME que pour les banques privées Delen et Van BredaConfirmation des perspectives : le bénéfice net de 2024 devrait être sup...

 PRESS RELEASE

Ackermans & van Haaren reports outstanding Q1-results at both DEME and...

Ackermans & van Haaren reports outstanding Q1-results at both DEME and at the private banks Delen and Van Breda, and gives confirmation of guidance: net profit of 2024 expected to be higher than last year Dear shareholder, Dear Madam, Dear Sir, Ackermans & van Haaren has published today its Trading Update on the 1st quarter of 2024, with the following key items: Outstanding Q1-results at both DEME and at the private banks Delen and Van BredaConfirmation of guidance: net profit of 2024 expected to be higher than last year Please find in annex the full press release ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch